Andhra Cements (ACL)

Cyclical

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹46.14
Market Cap₹425.28 Cr
P/E Ratio0
ROCE-10.52%
ROE-69.49%
Dividend Yield0%
Profit Growth-0.94%
Debt/Equity13.96
Sales Growth42.8%
Promoter Holding90%
52-Week Range₹40.5 — ₹100.01
SectorCement & Cement Products
Book Value₹8.76

Strengths

Concerns

AI Analysis

Let me begin with Graham's first rule: don't lose money. Andhra Cements today fails that test. The price is ₹54.93 and market cap ₹512 Cr, but the latest quarter tells an ugly story: sales of ₹110 Cr produced a net loss of ₹44 Cr. A business that loses 40% of every rupee of sales cannot compound capital. The P/E of 0.00 is not low valuation; it means earnings are absent. ROE is -69.49% and ROCE is -10.52%, so management is destroying value, not creating it. Debt/equity of 12.22 is terrifying. With ₹25.11 book value, the equity cushion is thin, and losses will eat it further. P/B of 2.19 offers no margin of safety for such poor returns. The Piotroski F-score of 3/9 reinforces the weak financial health. Promoter holding of 90% has some positive alignment, but it also means low free float and no accountability from minority shareholders. The 66% sales growth might look attractive, but growth with losses is just a faster way to burn cash. In cement, with high fixed costs and cyclical demand, this could be a temporary upswing that is not generating profit. There is no dividend yield to reward patience. The stock has fallen from its 52-week high of ₹109.99 to ₹54.93, but a falling price is not a bargain if the fundamentals are deteriorating. I see no moat, no pricing power, and a dangerously leveraged balance sheet. This is a business to watch, not to own. Unless the company can significantly reduce debt, improve operating margins, and convert sales growth into real earnings, the risk remains ruinous. My investment philosophy demands a healthy business at a fair price; Andhra Cements offers neither.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer